Literature DB >> 12875626

Chemomodulatory effect of Moringa oleifera, Lam, on hepatic carcinogen metabolising enzymes, antioxidant parameters and skin papillomagenesis in mice.

Rupjyoti Bharali1, Jawahira Tabassum, Mohammed Rekibul Haque Azad.   

Abstract

The modulatory effects of a hydro-alcoholic extract of drumsticks of Moringa oliefera Lam at doses of 125 mg/kg bodyweight and 250 mg/ kg body weight for 7 and 14 days, respectively, were investigated with reference to drug metabolising Phase I (Cytochrome b(5) and Cytochrome p(450) ) and Phase II (Glutathione-S- transferase) enzymes, anti-oxidant enzymes, glutathione content and lipid peroxidation in the liver of 6-8 week old female Swiss albino mice. Further, the chemopreventive efficacy of the extract was evaluated in a two stage model of 7,12 - dimethylbenz(a)anthracene induced skin papillomagenesis. Significant increase (p<0.05 to p<0.01) in the activities of hepatic cytochrome b(5), cytochrome p(450), catalase, glutathione peroxidase ( GPx ), glutathione reductase (GR), acid soluble sulfhydryl content (-SH ) and a significant decrease ( p<0.01 ) in the hepatic MDA level were observed at both dose levels of treatment when compared with the control values. Glutathione-S- transferase ( GST )activity was found to be significantly increased (p<0.01 ) only at the higher dose level. Butylated hydroxyanisol (BHA ) fed at a dose of 0.75% in the diet for 7 and 14 days (positive control ) caused a significant increase (p<0.05 to p<0.01) in the levels of hepatic phase I and phase II enzymes, anti- oxidant enzymes, glutathione content and a decrease in lipid peroxidation. The skin papillomagenesis studies demonstrated a significant decrease (p<0.05 ) in the percentage of mice with papillomas, average number of papillomas per mouse and papillomas per papilloma bearing mouse when the animals received a topical application of the extract at a dose of 5mg/ kg body weight in the peri-initiation phase 7 days before and 7 days after DMBA application, Group II ), promotional phase (from the day of croton oil application and continued till the end of the experiment, Group III ) and both peri and post initiation stages (from 7 days prior to DMBA application and continued till the end of the experiment, Group IV) compared to the control group (Group I ). The percentage inhibition of tumor multiplicity has been recorded to be 27, 72, and 81 in Groups II, III, and IV, respectively. These findings are suggestive of a possible chemopreventive potential of Moringa oliefera drumstick extract against chemical carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12875626

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  22 in total

Review 1.  Possible role of Moringa oleifera Lam. root in epithelial ovarian cancer.

Authors:  Chinmoy K Bose
Journal:  MedGenMed       Date:  2007-02-06

2.  Potential Chemoprevention of 7,12-Dimethylbenz[a]anthracene Induced Renal Carcinogenesis by Moringa oleifera Pods and Its Isolated Saponin.

Authors:  Veena Sharma; Ritu Paliwal
Journal:  Indian J Clin Biochem       Date:  2013-05-21

3.  Green-synthesized silver nanoparticles as a novel control tool against dengue virus (DEN-2) and its primary vector Aedes aegypti.

Authors:  Vasu Sujitha; Kadarkarai Murugan; Manickam Paulpandi; Chellasamy Panneerselvam; Udaiyan Suresh; Mathath Roni; Marcello Nicoletti; Akon Higuchi; Pari Madhiyazhagan; Jayapal Subramaniam; Devakumar Dinesh; Chithravel Vadivalagan; Balamurugan Chandramohan; Abdullah A Alarfaj; Murugan A Munusamy; Donald R Barnard; Giovanni Benelli
Journal:  Parasitol Res       Date:  2015-06-12       Impact factor: 2.289

4.  Moringa oleifera fruit induce apoptosis via reactive oxygen species-dependent activation of mitogen-activated protein kinases in human melanoma A2058 cells.

Authors:  Tae Eun Guon; Ha Sook Chung
Journal:  Oncol Lett       Date:  2017-05-31       Impact factor: 2.967

5.  Chemopreventive effect of piperine on mitochondrial TCA cycle and phase-I and glutathione-metabolizing enzymes in benzo(a)pyrene induced lung carcinogenesis in Swiss albino mice.

Authors:  K Selvendiran; C Thirunavukkarasu; J Prince Vijeya Singh; R Padmavathi; D Sakthisekaran
Journal:  Mol Cell Biochem       Date:  2005-03       Impact factor: 3.396

6.  Extension of life span and stress tolerance modulated by DAF-16 in Caenorhabditis elegans under the treatment of Moringa oleifera extract.

Authors:  Anita Prabhatsinh Chauhan; Mukesh Ghanshyam Chaubey; Stuti Nareshkumar Patel; Datta Madamwar; Niraj Kumar Singh
Journal:  3 Biotech       Date:  2020-11-04       Impact factor: 2.406

7.  Moringa oleifera hydroethanolic extracts effectively alleviate acetaminophen-induced hepatotoxicity in experimental rats through their antioxidant nature.

Authors:  Sharida Fakurazi; Syazana Akmal Sharifudin; Palanisamy Arulselvan
Journal:  Molecules       Date:  2012-07-10       Impact factor: 4.411

8.  Antioxidant activity and total phenolic content of Moringa oleifera leaves in two stages of maturity.

Authors:  S Sreelatha; P R Padma
Journal:  Plant Foods Hum Nutr       Date:  2009-12       Impact factor: 3.921

9.  Carbon and silver nanoparticles in the fight against the filariasis vector Culex quinquefasciatus: genotoxicity and impact on behavioral traits of non-target aquatic organisms.

Authors:  Kadarkarai Murugan; Devaraj Nataraj; Pari Madhiyazhagan; Vasu Sujitha; Balamurugan Chandramohan; Chellasamy Panneerselvam; Devakumar Dinesh; Ramachandran Chandirasekar; Kalimuthu Kovendan; Udaiyan Suresh; Jayapal Subramaniam; Manickam Paulpandi; Chithravel Vadivalagan; Rajapandian Rajaganesh; Hui Wei; Ban Syuhei; Al Thabiani Aziz; Mohamad Saleh Alsalhi; Sandhanasamy Devanesan; Marcello Nicoletti; Angelo Canale; Giovanni Benelli
Journal:  Parasitol Res       Date:  2015-11-28       Impact factor: 2.289

10.  Experimental Assessment of Moringa oleifera Leaf and Fruit for Its Antistress, Antioxidant, and Scavenging Potential Using In Vitro and In Vivo Assays.

Authors:  Suaib Luqman; Suchita Srivastava; Ritesh Kumar; Anil Kumar Maurya; Debabrata Chanda
Journal:  Evid Based Complement Alternat Med       Date:  2011-12-14       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.